| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
4
5
4
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
B-
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 1.67 | 1.67 |
| Stocks | 28.29 | 28.29 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 70.04 | 70.04 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Bayer AG | BAYN | --- | 2.34 |
| Nordea Bank AB | NRDEF | 24.0 | 2.12 |
| HSBC Holdings PLC | HBCYF | 4.07 | 2.1 |
| Gilead Sciences Inc | GILD | 36.53 | 1.88 |
| Salix Pharmaceuticals, Ltd. | SLXP | 29.2 | 1.77 |
| Macy's Inc | M | 15.07 | 1.73 |
| Itochu Corp. | 8001 | --- | 1.73 |
| Galp Energia | GALP | --- | 1.71 |
| Sanofi | SAN | --- | 1.7 |
| Credit Suisse Group | CSGN | --- | 1.69 |
